C
Cellectar Biosciences
A pharmaceutical research company specializing in cancer drugs
About Cellectar Biosciences
Cellectar Biosciences, Inc. is a clinical stage biopharmaceutical company dedicated to the discovery, development, and commercialization of drugs for cancer treatment. The company leverages its proprietary phospholipid drug delivery platform to create phospholipid drug conjugates (PDCs) that specifically target cancer cells. This targeted approach aims to improve the efficacy of cancer treatments while minimizing off-target effects, thereby enhancing patient safety.
Read full description
Cellectar operates in the biopharmaceutical sector, focusing on oncology. Its clients primarily include healthcare providers, research institutions, and potentially patients undergoing cancer treatment. The company's business model revolves around the development and commercialization of its proprietary PDCs. Revenue is generated through the sale of these drugs, partnerships, and potentially licensing agreements.
The market for Cellectar's products is highly specialized, targeting various forms of cancer. The company's innovative approach and proprietary technology position it as a significant player in the oncology drug development space.
At a glance
- Founded
- 2002
- Headquarters
- Madison, United States
- Listing
- IPO 2005
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Cellectar Biosciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Cancer Institute (NCI)
Series A1 investor entered at this stage
Venture Investors Health Fund
Series B and later9 investors entered at this stage
- NMNantahala Capital Management
Second Line
Janus Henderson Investors
Caligan Partners
Balyasny Asset Management- SMStonepine Capital Management
SilverArc Capital
StemPoint Capital
Empery Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cellectar Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellectar Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.